Ganesh Chavan faked his murder so that he could claim a Rs 1-crore life insurance policy. He murdered a hapless hitchhiker to fake his own death and even let his family grieve over him, only to be ...

Patil’s last rites were performed with full state honours following Lingayat traditions, in the presence of top national and state leaders. A seven-time Lok Sabha MP from Latur, he held key Union ...

Mumbai: The long-discussed Kalyan–Latur Expressway project moved a key step forward, with Maharashtra Chief Minister Devendra Fadnavis granting in-principle approval during a review meeting in Nagpur ...

The last time I wrote about Allogene Therapeutics, Inc. (ALLO) it was in a Seeking Alpha article entitled "Allogene: Two End Of 2024 Data Readouts With Improved Allogeneic CAR-T Products." I noted the ...

The combination of PD-L1 and CTLA-4 inhibition improves disease-free survival after surgery in patients with primary renal cell carcinoma, a phase 3 trial finds. For patients with renal cell carcinoma ...

Less than half of the healthcare providers correctly identified refractory chronic cough (RCC) as a cough lasting more than 8 weeks and not responding to treatment, based on survey data from more than ...

Former Valley Center High School and San Diego State quarterback Kevin Craft has been named head football coach at Riverside City College, taking over for his father Tom, who retired at the end of ...

RCC is a short-term, exchange-listed baby bond from Ready Capital, maturing in February 2026, offering an 8.5% yield to maturity. The bond's very short duration minimizes market risk, making solvency ...

Partial nephrectomy was associated with the highest survival rate among patients with localized RCC aged 75 years and older compared with radical nephrectomy, ablation, and surveillance. Despite its ...

A panelist discusses how, based on the NCCN guidelines for kidney cancer, third-line treatment options for this patient include cabozantinib, lenvatinib plus everolimus, tivozanib, and everolimus ...

Dr. Laurence Albiges discusses triplet therapies, highlighting which patients with RCC may garner the most benefit with this treatment intensification. The phase 3 COSMIC-313 trial evaluated Cabometyx ...